Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Bartlomiej Burzynski, Tomasz Jurys, Karolina Kwiatkowska, Katarzyna Cempa & Andrzej Paradysz. (2023) Physiotherapeutic assessment and management of overactive bladder syndrome: a case report. Physiotherapy Theory and Practice 39:3, pages 650-657.
Read now
Read now
Jan Krhut, Barbora Skugarevská, David Míka, Lars Lund & Peter Zvara. (2022) Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations. Research and Reports in Urology 14, pages 167-175.
Read now
Read now
Ghader Mohammadnezhad, Behniya Azadmehr & Nazila Yousefi. (2022) Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 22:8, pages 1187-1198.
Read now
Read now
Seungbeom Kim, Hyun Seok Na, Jong Mok Park & Jin Wook Kim. (2022) Novel botulinum neurotoxin-A tibial nerve perineural injection to alleviate overactive bladder symptoms in male rats. Animal Cells and Systems 26:6, pages 283-290.
Read now
Read now
Hadi Mostafaei, Shahrokh F. Shariat, Hanieh Salehi-Pourmehr, Florian Janisch, Keiichiro Mori, Fahad Quhal & Sakineh Hajebrahimi. (2020) The clinical pharmacology of the medical treatment for overactive bladder in adults. Expert Review of Clinical Pharmacology 13:7, pages 707-720.
Read now
Read now
Zana Saratlija Novakovic, Roberta Andrea Tesija & Livia Puljak. (2017) Association between metabolic syndrome and overactive bladder: a case–control study. Scandinavian Journal of Urology 51:6, pages 470-473.
Read now
Read now
Articles from other publishers (27)
Matthew R. Cooperberg, Rachel Mbassa, David Walker, William Meeks, Amy Lockefeer, Baoguo Jiang, Tina Li, Karissa Johnston & Raymond Fang. (2023) Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States. Therapeutic Advances in Urology 15, pages 175628722211505.
Crossref
Crossref
Karis Buford, Dhaval Jivanji & Allison Polland. (2022) Microhematuria in Women Presenting for Overactive Bladder. Current Urology Reports 24:1, pages 25-32.
Crossref
Crossref
Stavros Kontogiannis, Anastasios Athanasopoulos, Michail Tsagkarakis & Nikolaos Kontodimopoulos. (2021) Psychometric evaluation of the Overactive Bladder Questionnaire (OAB-q) for measuring quality of life and clinical implications in Greek patients with overactive bladder. International Urogynecology Journal 33:11, pages 3035-3043.
Crossref
Crossref
Kylie J. Mansfield, Zhuoran Chen, Kate H. Moore & Luke Grundy. (2022) Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms. Frontiers in Physiology 13.
Crossref
Crossref
Stephen R. Kraus, Junlong Li, Rita M. Kristy, Amy Lockefeer, Hongbo Yang, Mo Zhou & David R. Walker. (2022) Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States. Journal of International Medical Research 50:5, pages 030006052210981.
Crossref
Crossref
Abdullah Al-Danakh, Mohammed Safi, Mohammed Alradhi, Marwan Almoiliqy, Qiwei Chen, Murad Al-Nusaif, Xuehan Yang, Aisha Al-Dherasi, Xinqing Zhu & Deyong Yang. (2022) Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinson's Disease 2022, pages 1-12.
Crossref
Crossref
Григорий Георгиевич Кривобородов, Николай Сергеевич Ефремов, Денис Александрович Ширин, Алина Андреевна Гонтарь & Ольга Николаевна Ткачева. 2022. Diagnosis and treatment principles of non-neurogenic lower urinary tract symptoms (LUTS) in older patients. Diagnosis and treatment principles of non-neurogenic lower urinary tract symptoms (LUTS) in older patients.
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson & Rajender R. Aparasu. (2021) Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society 70:3, pages 820-830.
Crossref
Crossref
Jose C. Truzzi, Marie C. Lapitan, Natassia C. Truzzi, Valerio Iacovelli & Marcio A. Averbeck. (2022) Botulinum toxin for treating overactive bladder in men: A systematic review. Neurourology and Urodynamics 41:3, pages 710-723.
Crossref
Crossref
Jan Krhut, Michal Rejchrt, Barbora Skugarevska, Michal Grepl & Peter Zvara. (2022) Peroneal Electrical Transcutaneous NeuroModulation as a New Treatment for Patients with Overactive Bladder: An Initial Clinical Experience. Urologia Internationalis 106:7, pages 658-663.
Crossref
Crossref
Jan Krhut, Lukas Peter, Michal Rejchrt, Martin Slovak, Barbora Skugarevska & Peter Zvara. (2021) Peroneal Electric Transcutaneous NeuroModulation (eTNM®): A Novel Method for the Treatment of the Overactive Bladder. Journal of Healthcare Engineering 2021, pages 1-12.
Crossref
Crossref
Habiba Shabir, Sana Hashemi, Moussa Al-Rufayie, Tayo Adelowo, Umar Riaz, Umayair Ullah, Benyamin Alam, Mehreen Anwar & Laure de Preux. (2021) Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome. International Journal of Environmental Research and Public Health 18:16, pages 8743.
Crossref
Crossref
Folgerdiena M. Vries, Julia C. Stingl & Monique M.B. Breteler. (2021) Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland Study. British Journal of Clinical Pharmacology 87:7, pages 2732-2756.
Crossref
Crossref
Mathias Reekmans, Janine M. W. Janssen, Desiree M. J. Vrijens, Martijn A. C. Smits, Gommert A. Koeveringe & Philip E. V. A. Van Kerrebroeck. (2021) Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients. Neurourology and Urodynamics 40:5, pages 1120-1125.
Crossref
Crossref
G. G. Krivoborodov, E. I. Tur & D. A. Shirin. (2021) Hyperactive bladder: concept of disease and paradigms in the treatment. Meditsinskiy sovet = Medical Council:4, pages 121-126.
Crossref
Crossref
Andrzej Wróbel, Anna Serefko, Aleksandra Szopa & Ewa Poleszak. (2021) Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity. Frontiers in Pharmacology 11.
Crossref
Crossref
Edwin Utomo, Farhat ., Melvin Nova Gunawanto Barus & Mohd. Rhiza Z. Tala. (2021) Brain-derived neurotrophic factor, nerve growth factor, and high sensitivity C-reactive protein levels in urine in overactive bladder patients: a meta-analysis. F1000Research 10, pages 747.
Crossref
Crossref
Satoru Takahashi, Daisuke Kato, Hiromi Tabuchi & Satoshi Uno. (2020) Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post‐marketing study. LUTS: Lower Urinary Tract Symptoms 13:1, pages 79-87.
Crossref
Crossref
Douglas Barthold, Zachary A. Marcum, Shelly L. Gray & Julie Zissimopoulos. (2020)
Alzheimer's disease and related dementias risk: Comparing users of non‐selective and
M3
‐selective bladder antimuscarinic drugs
. Pharmacoepidemiology and Drug Safety 29:12, pages 1650-1658.
Crossref
Crossref
Valentina Lucia La Rosa, Thaís Duarte de Campos da Silva, Arielle Rosa de Oliveira, Taís Marques Cerentini, Patricia Viana da Rosa & Luis Henrique Telles da Rosa. (2019) Behavioral therapy versus drug therapy in individuals with idiopathic overactive bladder: A systematic review and meta-analysis. Journal of Health Psychology 25:5, pages 573-585.
Crossref
Crossref
Andrzej Wróbel, Aleksandra Szopa, Anna Serefko & Ewa Poleszak. (2020) A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors. Molecules 25:6, pages 1384.
Crossref
Crossref
Magdaléna Hagovska, Ján Švihra, Alena Buková, Agata Horbacz, Dana Dračková, Ján Lupták & Ján Švihra Jr.. (2020) The Relationship between Overweight and Overactive Bladder Symptoms. Obesity Facts 13:3, pages 297-306.
Crossref
Crossref
Yaoguang Zhang, Peng Zhang, Xiaojun Tian, Guoqing Chen, Yan Li, Yong Zhang, Zhihui Xu, Zhongqing Wei, Wei Zhang, Lulin Ma, Benkang Shi, Limin Liao & Jianye Wang. (2019) Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device. World Journal of Urology 37:11, pages 2481-2492.
Crossref
Crossref
Gary Puckrein, David Walker, Liou Xu, Peter Congdon & Katherine Gooch. (2019) The Prevalence and Forecast Prevalence of Overactive Bladder in the Medicare Population. Clinical Medicine Insights: Urology 12, pages 117956111984746.
Crossref
Crossref
Kaan Kaltalioglu, Fatmanur Tugcu-Demiroz, Fusun Acarturk, Barbaros Balabanli & Sule Coskun-Cevher. (2018) Comparison of Oxidative Effects of Two Different Administration Form of Oxybutynin in the Potential Target Tissues. Advances in Urology 2018, pages 1-5.
Crossref
Crossref
Kristian D. Stensland, Bennett Sluis, Jay Vance, Jared P. Schober, Lara S. MacLachlan & Arthur P. Mourtzinos. (2018) Predictors of Nerve Stimulator Success in Patients With Overactive Bladder. International Neurourology Journal 22:3, pages 206-211.
Crossref
Crossref
Yolanda Cruz, R. A. Lucio & J. L. Palacios. (2017) Neural and Endocrine Factors Contribute to the Comorbidity of Urinary and Sexual Dysfunctions. Current Sexual Health Reports 9:4, pages 251-261.
Crossref
Crossref